Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures



Status:Recruiting
Healthy:No
Age Range:18 - 90
Updated:11/8/2017
Start Date:November 5, 2016
End Date:September 5, 2018
Contact:Thomas Lawson, PhD
Email:thom@urosee.com
Phone:510 206 1794

Use our guide to learn which trials are right for you!

Evaluation of the Performance of a Disposable Cystoscope System for Direct Visualization of the Urethra and Bladder

This is a prospective, multicenter, single-arm, open-label clinical usability study in
subjects who are candidates for office diagnostic cystoscopy. The primary objective of this
initial device assessment is to evaluate the performance of a new cystoscope for direct
visualization of the urethra and bladder.

A new cystoscope has been designed for female diagnostic cystoscopy, with a focus on
promoting patient comfort, tolerability and safety while improving office efficiency. The
cystoscope, named the Uro-C, is light-weight, ergonomic, handheld, battery-operated portable
system that integrates a disposable cannula with a reusable handle that contains video
electronics, is wireless capable, and has a liquid crystal display (LCD) monitor. Cystoscopy
with the new system is performed in a standard manner to cystoscopy with currently available
endoscopes, so risks are no different than when currently available endoscopes are used.

This is a prospective, multi-center, single-arm, open-label clinical usability study in
subjects who are candidates for office diagnostic cystoscopy. The primary objective of this
initial device assessment is to evaluate the performance of the cystoscope for direct
visualization of the urethra and bladder.

Inclusion Criteria:

1. Otherwise healthy adult (18 years of age or older) women presenting for cystoscopy for
diagnostic purposes; and

2. Ambulatory and able to undergo routine cystoscopy in the lithotomy position.

Exclusion Criteria:

1. History of prior bladder/urethral surgery other than TURBT; or

2. History of interstitial cystitis; or

3. Presence of urinary tract infection (UTI); or

4. Gross hematuria; or

5. History of pelvic radiation therapy; or

6. Procidentia; or

7. Unable to read, understand, and/or provide a ranking of pain level during the
procedure; or

8. Unable or unwilling to provide consent to participation in the study.
We found this trial at
1
site
7500 Smoke Ranch Road
Las Vegas, Nevada 89128
Phone: 702-233-0727
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials